Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 593 clinical trials
Featured trial
Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma

, safety, and tolerability of rilzabrutinib in adult participants (aged 18-70 years) with moderate-to-severe asthma who are not well controlled on inhaled ICS/LABA therapy. Study treatment includes

  • 4 views
  • 02 Dec, 2022
  • 23 locations
Featured trial
A Randomized, Double-blind, Head-to-head Comparison of Dupilumab Versus Omalizumab in Severe Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) and Comorbid Asthma Patients (EVEREST)

evaluate the effect of dupilumab on CRSwNP overall disease severity at Week 24 compared to omalizumab To evaluate the effect of dupilumab on asthma control at Week 24 compared to omalizumab

  • 41 views
  • 02 Dec, 2022
  • 72 locations
Featured trial
Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) (AERIFY-2)  

Primary Objective: Primary population (former smokers cohort): Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or-severe COPD exacerbations in former smokers with moderate-to-severe COPD Secondary Objectives: Primary population (former smokers cohort): Evaluate the efficacy of itepekimab compared with placebo on pulmonary function in former …

  • 738 views
  • 02 Dec, 2022
  • 67 locations
Featured trial
Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma (TIDE-asthma)  

efficacy, safety, and tolerability of add-on therapy with amlitelimab in adult participants with moderate-to-severe asthma. Study details include: The study duration (per participant

  • 14 views
  • 02 Dec, 2022
  • 5 locations
Featured trial
Dupilumab in CRSsNP (Liberty CRSsNP ORION)  

and 52 compared to placebo To evaluate the effect of dupilumab at Weeks 24 and 52 in the subgroups of participants with comorbid asthma compared to placebo To evaluate the ability

facial pain
rhinorrhea
acute sinusitis
obstruction
asthma
  • 20 views
  • 01 Dec, 2022
  • 9 locations
Featured trial
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)

The purpose of the study is to assess the efficacy and safety of ruxolitinib cream in children with Atopic Dermatitis. This is a randomized, double-blind, Vehicle Controlled study. Participants will be randomized 2:2:1 to blinded treatment with ruxolitinib cream 0.75% ,1.5% , or vehicle cream, with stratification by baseline IGA …

  • 53 views
  • 07 Oct, 2022
  • 52 locations
Featured trial
Asthma

Adults with Moderate-to-Severe Uncontrolled Asthma.

  • 33 views
  • 01 Feb, 2022
  • 1 location
Featured trial
Asthma research study for those with Eosinophilic Asthma

This study is testing the safety of an investigational medication to see how well is works for the treatment of asthma in patients with high eosinophils. This study has 10 clinical visits

  • 760 views
  • 26 Sep, 2019
  • 1 location
Featured trial
Severe Uncontrolled Asthma

Pharmaceutical Research & Consulting is enrolling patients in an asthma research study.

  • 16 views
  • 27 Sep, 2022
  • 1 location
Featured trial
MODERATE TO SEVERE ASTHMA

AN ASTHMA ATTACK, ALSO CALLED AN ASTHMA EXACERBATION, IS WHEN THE AIRWAYS BECOME SWOLLEN AND INFLAMED.  

  • 144 views
  • 11 Sep, 2019
  • 1 location